Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by Padinaon Sep 09, 2020 8:57am
129 Views
Post# 31525712

RE:RE:0 04

RE:RE:0 04@ Alan,

You are right 50% is good. The naysayers will never see anything good with VXL. If the stock had gone parabolic with over 200% on that news, i am sure they will be here crying foul that such news ought not to generate such price action.  We are here because we want our investment to grow. The naysayers have no shares which makes me wonder why they cant move on .They are probably shorting the stock - so any good news is a bad news to them.

Per the 8 weeks comment, i think u are right on that too. But if the market would just do a comparation with others, it will be clear that the 8 weeks is actually a terrific timeline.
Here are some of the tickers i own and their timelines

SRNE: Preclinicals was done May, we are still waiting for human trials almost 4 months now

HTBX: Preclinicals result was released August. One months later we dont even have an update as to when human trial will start

VBIV: Preclinicals released in August. They also got $56million Canadian govt funding. The next phase on there vaccine will be in December 2020
iBio: Preclinicals released in July, no timeline yet as to what mnext to expect.

If the market also considers that Sept & Oct is a very busy month in Isreal with various holidays and Observance iotwill become clear that the 8 weeks is actually a terrific timeline.

And who knows maybe the market would be caught napping once again with a PR b4 8 weeks elapses
<< Previous
Bullboard Posts
Next >>